These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1341 related articles for article (PubMed ID: 36106706)

  • 1. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective.
    Nouri Z; Fakhri S; El-Senduny FF; Sanadgol N; Abd-ElGhani GE; Farzaei MH; Chen JT
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease.
    Goyal A; Solanki K; Verma A
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23619. PubMed ID: 38091364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review.
    Singh A; Kumar Singh N
    Curr Pharm Biotechnol; 2024; 25(9):1112-1123. PubMed ID: 37526460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review.
    Khaafi F; Javadi B
    Mini Rev Med Chem; 2023; 23(19):1912-1925. PubMed ID: 36998129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Potential of Hesperidin as Therapeutic Agent in the Treatment of Brain Disorders: Preclinical Evidence-based Review.
    Bansal K; Singh V; Singh S; Mishra S
    Curr Mol Med; 2024; 24(3):316-326. PubMed ID: 36959141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease.
    Verma A; Chaudhary S; Solanki K; Goyal A; Yadav HN
    Chem Biol Drug Des; 2024 Jan; 103(1):e14426. PubMed ID: 38230775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint.
    Emran TB; Islam F; Nath N; Sutradhar H; Das R; Mitra S; Alshahrani MM; Alhasaniah AH; Sharma R
    Life (Basel); 2022 Dec; 13(1):. PubMed ID: 36676048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Khezri MR; Ghasemnejad-Berenji M
    Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
    Nakajima A; Ohizumi Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naringenin: its chemistry and roles in neuroprotection.
    Atoki AV; Aja PM; Shinkafi TS; Ondari EN; Awuchi CG
    Nutr Neurosci; 2024 Jun; 27(6):637-666. PubMed ID: 37585716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
    Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
    Javed H; Mohamed Fizur NM; Jha NK; Ashraf GM; Ojha S
    Curr Neuropharmacol; 2023; 21(6):1421-1432. PubMed ID: 36567278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
    Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
    CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration.
    Mittal P; Goyal R; Kapoor R; Wan C; Gautam RK
    Curr Neuropharmacol; 2023; 21(4):777-786. PubMed ID: 36825704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic use of plant flavonoids in AD and PD.
    Meng-Zhen S; Ju L; Lan-Chun Z; Cai-Feng D; Shu-da Y; Hao-Fei Y; Wei-Yan H
    Heliyon; 2022 Nov; 8(11):e11440. PubMed ID: 36387565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
    Nowell J; Blunt E; Gupta D; Edison P
    Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Role of Phytochemicals.
    Velmurugan BK; Rathinasamy B; Lohanathan BP; Thiyagarajan V; Weng CF
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30262792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.